Evidence map›Paper›PMID 20524067›Full record

ArticleInternational urology and nephrology2011

Antimicrobial susceptibility of pediatric uropathogens in Thrace, Greece.

Elpis Mantadakis, Aggelos Tsalkidis, Maria Panopoulou, Spyridon Pagkalis, Gregory Tripsianis, Mathew E Falagas, Mathew Falagas, Sophia Kartali-Ktenidou, Athanassios Chatzimichael

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in International urology and nephrology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. In vitro antimicrobial activity and clinical use of trimethoprim-sulfamethoxazole for infections due to KPC-producing Gram-negative pathogens: a review.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Review
  4. Article
  5. Review
  6. Antibiotic Resistance in Pediatric Urinary Tract Infections.Current infectious disease reports · 2016
    Review
  7. Article
  8. Article
  9. Review
  10. Clinical Value of an Ambulatory-Based Antibiogram for Uropathogens in Children.Journal of the Pediatric Infectious Diseases Society · 2012
    Article
  11. Article
4 · The record

Corrections and comments

  • Erratum issued
    Falagas, Mathew [corrected to Falagas, Mathew E]
5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Elpis MantadakisDepartment of Pediatrics, University General District Hospital of Alexandroupolis and Democritus University of Thrace Medical School, 68100 Alexandroupolis, Thrace, Greece. emantada@med.duth.gr
Aggelos Tsalkidis
Maria Panopoulou
Spyridon Pagkalis
Gregory Tripsianis
Mathew E Falagas
Mathew Falagas
Sophia Kartali-Ktenidou
Athanassios Chatzimichael
Democritus University of Thrace · GRTufts University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to investigate the bacterial pathogens involved in pediatric urinary tract infections (UTIs) in a tertiary general hospital located in the Thrace province of Northern Greece over a 69-month period (1/2003 to 9/2008), and their antibiotic susceptibility patterns. A total of 622 episodes of UTIs in 508 children were identified. Median age of all children was 16 months (range 1 month to 14 years). Boys were significantly younger than girls (9 months vs. 24 months). Escherichia coli was the most common uropathogen and responsible for 69.1% of UTIs. Approximately half of E. coli isolates were resistant to ampicillin and 20.5% to trimethoprim/sulfamethoxazole (TMP/SMX). E. coli resistance to second-generation and third-generation cephalosporins was <4%, to aminoglycosides <8%, and to nitrofurantoin 4.4%. Pediatric E. coli urine isolates were significantly more resistant to ampicillin and ticarcillin and more sensitive to quinolones compared to adult E. coli uropathogens identified in the same hospital. E. coli resistance to ampicillin and amoxicillin/clavulanic acid was significantly higher in boys 12-23 months-old compared to girls of the same age. In conclusion, nitrofurantoin is a very good choice for chemoprophylaxis. Amoxicillin/clavulanic acid, second-generation cephalosporins, and TMP/SMX are appropriate choices for oral empirical treatment of UTIs. Parenteral aminoglycosides and second and third-generation cephalosporins are excellent treatment choices for inpatient therapy. Finally, sex and age are additional factors that should be taken into account when choosing empirical therapy for children with UTIs.

Indexed as

AdolescentChildChild, PreschoolEscherichia coliFemaleGreeceHumansInfantMaleMicrobial Sensitivity TestsProteusRetrospective StudiesUrinary Tract Infections

Identifiers

PMID20524067
OpenAlexW1966830421

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.